Business Features

June 06, 2023

In this episode, Siegfried Schmitt, vice president, Technical at Parexel, discusses the state of biopharma investment in 2023.

June 03, 2023

What factors do CDMOs consider vital to their success?

June 02, 2023

COVID-19 has raised the specter of pandemic planning and the question of what can be done now to prevent future disaster.

May 18, 2023

Context surrounding the Inflation Reduction Act is necessary for a comprehensive understanding of the global biopharma market.

May 03, 2023

The market potential of nucleic acid-based therapies have been pushed into the spotlight following the success of the COVID-19 vaccines.

May 02, 2023

The engine that drives pharmaceuticals forward, its workforce, is now very low on fuel.

April 02, 2023

What can we take away from Pfifzer's acquisition of Seagen?

April 02, 2023

Direct-to-consumer drug advertising has developed as a cottage industry which has been used to increase prescriptions immensely.

March 03, 2023

EnteroBiotix is harnessing the power of the microbiome to target an array of diseases.